Worldwide, one out of every third person has cancer or risks having cancer at some point in their lives. More than 10 million people are diagnosed with cancer worldwide. Thus, cancer is one of the top health challenges that every country has to face today. With the increase in knowledge of the various cancer types and improvement in technology that helps drive the cancer treatment strategy to the patients, the cancer patients are getting relief but it is not enough. Today, the focus is more on the cancer prevention than that of cancer treatment.
Till now, the oncologists have been focussing on cancer treatment and how to help their patients in managing their malignancies to slow cancer. With the advancement in cancer research and technology, new tools are being developed to help in managing the lesion at an early stage to reduce the risk of cancer and increasing life expectancy. Till a few decades ago, anyone with cancer had slim chances of surviving, but today it can not only be diagnosed at an early stage, but be treated and also prevent it from occurring. Check classroomvoices.org to read more about Mikhail.
One person who has been recognized for his work on cancer drugs and cancer treatments is Mikhail Blagosklonny. He is known for advocating the use of the drug Rapamycin that has helped increased the longevity for patients with cancer. He has also performed researches on the process of aging and many written many research papers that have been published in the top journals. He has written about 270 papers and has approximately 25,000 citations to his record.
Mikhail Blagosklonny is the professor of Oncology at the renowned Roswell Park Cancer Institute where he was appointed in the year 2009. Before taking up this position, he was working at the Ordway Research Institute in Albany at the position of Senior Scientist where he was working since 2002. Previously, he has also worked in a senior capacity at the New York Medical College in Valhalla. Throughout his career, he has risen to the top ranks in colleges and research organizations because of his zeal for cancer treatment and to provide his community with a proven system of cancer treatment that is affordable for everyone. Visit ResearchGate to know more about Mikhail’s latest work.